BioAlliance Pharma: Key Milestones and Consolidated Accounts for the First Semester of 2012  
9/13/2012 10:17:43 AM

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Euronext Paris - BIO) (Paris:BIO), an innovative Company dedicated to the development of orphan oncology products and to supportive care products, today publishes its consolidated half-year accounts as of June 30, 2012, and the major key milestones recently achieved.